$ETNB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in 89bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in 89bio, Inc.. Get notifications about new insider transactions in 89bio, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2021 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Sell | S | 27.60 | 850 | 23,460 | 0 | 850 to 0 (-100.00 %) |
| Apr 20 2021 | ETNB | 89bio, Inc. | Martins Ryan | Chief Financial Off ... | Option Exercise | M | 3.11 | 10,000 | 31,100 | 84,901 | |
| Apr 20 2021 | ETNB | 89bio, Inc. | Martins Ryan | Chief Financial Off ... | Sell | S | 25.00 | 10,000 | 250,000 | 7,500 | 17.5 K to 7.5 K (-57.14 %) |
| Apr 20 2021 | ETNB | 89bio, Inc. | Martins Ryan | Chief Financial Off ... | Buy | M | 3.11 | 10,000 | 31,100 | 17,500 | 7.5 K to 17.5 K (+133.33 %) |
| Apr 19 2021 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | DiRocco Derek | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | DiRocco Derek | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Zoth Lota S. | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Zoth Lota S. | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Altschuler Steven | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Altschuler Steven | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Option Exercise | M | 1.93 | 7,000 | 13,510 | 60,203 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Option Exercise | M | 1.93 | 7,000 | 13,510 | 60,203 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Sell | S | 24.22 | 7,000 | 169,540 | 0 | 7 K to 0 (-100.00 %) |
| Apr 19 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Sell | S | 24.22 | 7,000 | 169,540 | 0 | 7 K to 0 (-100.00 %) |
| Apr 19 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Buy | M | 1.93 | 7,000 | 13,510 | 7,000 | 0 to 7 K |
| Apr 19 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Buy | M | 1.93 | 7,000 | 13,510 | 7,000 | 0 to 7 K |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | M | 3.11 | 13,637 | 42,411 | 22,730 | |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | M | 1.93 | 6,447 | 12,443 | 2,933 | |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | M | 1.93 | 60,820 | 117,383 | 27,647 | |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | M | 3.11 | 13,637 | 42,411 | 80,904 | 67.3 K to 80.9 K (+20.27 %) |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | M | 1.93 | 6,447 | 12,443 | 67,267 | 60.8 K to 67.3 K (+10.60 %) |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | M | 1.93 | 60,820 | 117,383 | 60,820 | 0 to 60.8 K |
| Feb 17 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Option Exercise | M | 1.93 | 7,000 | 13,510 | 74,203 | |
| Feb 17 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Sell | S | 23.39 | 7,000 | 163,730 | 0 | 7 K to 0 (-100.00 %) |
| Feb 17 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Buy | M | 1.93 | 7,000 | 13,510 | 7,000 | 0 to 7 K |
| Feb 09 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Option Exercise | A | 23.01 | 32,500 | 747,825 | 32,500 | |
| Feb 09 2021 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
| Feb 09 2021 | ETNB | 89bio, Inc. | PALEKAR ROHAN | Chief Executive Off ... | Option Exercise | A | 23.01 | 203,750 | 4,688,288 | 203,750 | |
| Feb 09 2021 | ETNB | 89bio, Inc. | PALEKAR ROHAN | Chief Executive Off ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Feb 09 2021 | ETNB | 89bio, Inc. | Martins Ryan | Chief Financial Off ... | Option Exercise | A | 23.01 | 57,500 | 1,323,075 | 57,500 | |
| Feb 09 2021 | ETNB | 89bio, Inc. | Martins Ryan | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Feb 09 2021 | ETNB | 89bio, Inc. | Le-Nguyen Quoc | See Remarks | Option Exercise | A | 23.01 | 67,500 | 1,553,175 | 67,500 | |
| Feb 09 2021 | ETNB | 89bio, Inc. | Le-Nguyen Quoc | See Remarks | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Feb 09 2021 | ETNB | 89bio, Inc. | Le-Nguyen Quoc | See Remarks | Option Exercise | A | 23.01 | 67,500 | 1,553,175 | 67,500 | |
| Feb 09 2021 | ETNB | 89bio, Inc. | Le-Nguyen Quoc | See Remarks | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Dec 18 2020 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Option Exercise | M | 1.93 | 7,000 | 13,510 | 88,203 | |
| Dec 18 2020 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Sell | S | 27.04 | 7,000 | 189,280 | 0 | 7 K to 0 (-100.00 %) |
| Dec 18 2020 | ETNB | 89bio, Inc. | Waisbourd Ram | See Remarks | Buy | M | 1.93 | 7,000 | 13,510 | 7,000 | 0 to 7 K |
| Nov 18 2020 | ETNB | 89bio, Inc. | Le-Nguyen Quoc | See Remarks | Option Exercise | M | 3.11 | 4,548 | 14,144 | 21,938 | |
| Nov 18 2020 | ETNB | 89bio, Inc. | Le-Nguyen Quoc | See Remarks | Sell | S | 28.11 | 4,548 | 127,844 | 0 | 4.5 K to 0 (-100.00 %) |
| Nov 18 2020 | ETNB | 89bio, Inc. | Le-Nguyen Quoc | See Remarks | Buy | M | 3.11 | 4,548 | 14,144 | 4,548 | 0 to 4.5 K |
| Nov 18 2020 | ETNB | 89bio, Inc. | Waisbourd Ram | COO and Chief Busin ... | Option Exercise | M | 1.93 | 7,000 | 13,510 | 95,203 | |
| Nov 18 2020 | ETNB | 89bio, Inc. | Waisbourd Ram | COO and Chief Busin ... | Sell | S | 27.39 | 7,000 | 191,730 | 0 | 7 K to 0 (-100.00 %) |
| Nov 18 2020 | ETNB | 89bio, Inc. | Waisbourd Ram | COO and Chief Busin ... | Buy | M | 1.93 | 7,000 | 13,510 | 7,000 | 0 to 7 K |
| Sep 23 2020 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Sell | S | 28.00 | 137,500 | 3,850,000 | 1,864,721 | 2 M to 1.9 M (-6.87 %) |
| Sep 23 2020 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Sell | S | 28.00 | 137,500 | 3,850,000 | 1,864,721 | 2 M to 1.9 M (-6.87 %) |
| Sep 23 2020 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Sell | S | 28.00 | 137,500 | 3,850,000 | 1,864,721 | 2 M to 1.9 M (-6.87 %) |
| Sep 23 2020 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Sell | S | 28.00 | 137,500 | 3,850,000 | 1,864,721 | 2 M to 1.9 M (-6.87 %) |
| Sep 21 2020 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 28.00 | 1,300,000 | 36,400,000 | 4,736,214 | 3.4 M to 4.7 M (+37.83 %) |
| Jul 14 2020 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | P | 27.50 | 109,090 | 2,999,975 | 2,600,877 | 2.5 M to 2.6 M (+4.38 %) |
| Jul 14 2020 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | P | 27.50 | 109,090 | 2,999,975 | 2,600,877 | 2.5 M to 2.6 M (+4.38 %) |
| Jul 14 2020 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Option Exercise | A | 24.29 | 7,000 | 170,030 | 7,000 | |
| Jul 14 2020 | ETNB | 89bio, Inc. | Altschuler Steven | Director | Option Exercise | A | 24.29 | 7,000 | 170,030 | 7,000 | |
| Jul 14 2020 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | A | 24.29 | 7,000 | 170,030 | 7,000 | |
| Jul 14 2020 | ETNB | 89bio, Inc. | DiRocco Derek | Director | Option Exercise | A | 24.29 | 7,000 | 170,030 | 7,000 | |
| Jul 14 2020 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | A | 24.29 | 7,000 | 170,030 | 7,000 | |
| Jul 10 2020 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 27.50 | 275,000 | 7,562,500 | 3,436,214 | 3.2 M to 3.4 M (+8.70 %) |
| Jun 16 2020 | ETNB | 89bio, Inc. | Zoth Lota S. | Director | Option Exercise | A | 24.05 | 20,000 | 481,000 | 20,000 | |
| Apr 07 2020 | ETNB | 89bio, Inc. | DiRocco Derek | Director | Option Exercise | A | 21.40 | 7,000 | 149,800 | 7,000 | |
| Apr 07 2020 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | A | 21.40 | 7,000 | 149,800 | 7,000 | |
| Apr 07 2020 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Option Exercise | A | 21.40 | 7,000 | 149,800 | 7,000 | |
| Apr 07 2020 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | A | 21.40 | 7,000 | 149,800 | 7,000 | |
| Mar 25 2020 | ETNB | 89bio, Inc. | Altschuler Steven | Director | Option Exercise | A | 23.22 | 40,000 | 928,800 | 40,000 | |
| Mar 25 2020 | ETNB | 89bio, Inc. | Altschuler Steven | Director | Option Exercise | A | 23.22 | 40,000 | 928,800 | 40,000 | |
| Mar 16 2020 | ETNB | 89bio, Inc. | Waisbourd Ram | COO and Chief Busin ... | Option Exercise | A | 32.50 | 30,000 | 975,000 | 30,000 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Option Exercise | C | 0.00 | 5,500,001 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Option Exercise | C | 0.00 | 5,500,001 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | C | 0.00 | 884,671 | 0 | 1,134,671 | 250 K to 1.1 M (+353.87 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | C | 0.00 | 884,671 | 0 | 1,134,671 | 250 K to 1.1 M (+353.87 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | P | 16.00 | 250,000 | 4,000,000 | 250,000 | 0 to 250 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | P | 16.00 | 250,000 | 4,000,000 | 250,000 | 0 to 250 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | C | 0.00 | 10,327,777 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | C | 0.00 | 10,327,777 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | C | 0.00 | 1,661,214 | 0 | 3,161,214 | 1.5 M to 3.2 M (+110.75 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | C | 0.00 | 1,661,214 | 0 | 3,161,214 | 1.5 M to 3.2 M (+110.75 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 16.00 | 1,500,000 | 24,000,000 | 1,500,000 | 0 to 1.5 M |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 16.00 | 1,500,000 | 24,000,000 | 1,500,000 | 0 to 1.5 M |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | C | 0.00 | 366,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | C | 0.00 | 58,978 | 0 | 77,728 | 18.8 K to 77.7 K (+314.55 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | C | 0.00 | 366,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | P | 16.00 | 18,750 | 300,000 | 18,750 | 0 to 18.8 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | C | 0.00 | 58,978 | 0 | 77,728 | 18.8 K to 77.7 K (+314.55 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | P | 16.00 | 18,750 | 300,000 | 18,750 | 0 to 18.8 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
Page: 1